Zolmax

Q1 2024 Earnings Forecast for Bandwidth Inc. Issued By Zacks Research (NASDAQ:BAND)

Posted by John Perry on Apr 1st, 2023

Bandwidth Inc. (NASDAQ:BAND – Get Rating) – Research analysts at Zacks Research boosted their Q1 2024 EPS estimates for Bandwidth in a note issued to investors on Monday, March 27th. Zacks Research analyst S. Bose now... More »

Beauty Health’s (SKIN) “Buy” Rating Reaffirmed at Canaccord Genuity Group

Posted by Wayne Rhoads on Apr 1st, 2023

Canaccord Genuity Group restated their buy rating on shares of Beauty Health (NASDAQ:SKIN – Get Rating) in a research report report published on Tuesday morning, Benzinga reports. They currently have a $18.00 price objective... More »

Rush Street Interactive (NYSE:RSI) Receives Market Outperform Rating from JMP Securities

Posted by Bonnie Powley on Apr 1st, 2023

JMP Securities restated their market outperform rating on shares of Rush Street Interactive (NYSE:RSI – Get Rating) in a research report released on Tuesday, Benzinga reports. They currently have a $8.00 price target on the... More »

Citigroup Trims Sabra Health Care REIT (NASDAQ:SBRA) Target Price to $10.50

Posted by Wayne Rhoads on Apr 1st, 2023

Sabra Health Care REIT (NASDAQ:SBRA – Get Rating) had its price objective lowered by Citigroup from $13.00 to $10.50 in a report published on Tuesday morning, Benzinga reports. Citigroup currently has a neutral rating on the... More »

Lyft (NASDAQ:LYFT) Receives “Sector Perform” Rating from Royal Bank of Canada

Posted by Wayne Rhoads on Apr 1st, 2023

Royal Bank of Canada reaffirmed their sector perform rating on shares of Lyft (NASDAQ:LYFT – Get Rating) in a research report report published on Tuesday morning, Benzinga reports. Royal Bank of Canada currently has a $11.00... More »

Roth Mkm Trims Real Good Food (NASDAQ:RGF) Target Price to $7.00

Posted by Wayne Rhoads on Apr 1st, 2023

Real Good Food (NASDAQ:RGF – Get Rating) had its price target cut by Roth Mkm from $12.00 to $7.00 in a research report sent to investors on Tuesday, Benzinga reports. They currently have a buy rating on the stock. Separately,... More »

JMP Securities Reiterates Market Outperform Rating for Incyte (NASDAQ:INCY)

Posted by Alphonse Anthony on Apr 1st, 2023

JMP Securities reissued their market outperform rating on shares of Incyte (NASDAQ:INCY – Get Rating) in a report published on Tuesday, Benzinga reports. They currently have a $113.00 price objective on the biopharmaceutical... More »

Generation Income Properties (NASDAQ:GIPR) Receives “Buy” Rating from EF Hutton Acquisition Co. I

Posted by Bonnie Powley on Apr 1st, 2023

EF Hutton Acquisition Co. I restated their buy rating on shares of Generation Income Properties (NASDAQ:GIPR – Get Rating) in a research note released on Tuesday, Benzinga reports. The firm currently has a $6.00 price objective... More »

Gannett (NYSE:GCI) Price Target Cut to $1.70 by Analysts at Citigroup

Posted by Wayne Rhoads on Apr 1st, 2023

Gannett (NYSE:GCI – Get Rating) had its target price lowered by Citigroup from $2.60 to $1.70 in a research note issued to investors on Tuesday morning, Benzinga reports. Citigroup currently has a sell rating on the stock. Separately,... More »

Nutrien’s (NTR) Hold Rating Reaffirmed at Erste Group Bank

Posted by Wayne Rhoads on Apr 1st, 2023

Erste Group Bank reiterated their hold rating on shares of Nutrien (NYSE:NTR – Get Rating) in a research note released on Tuesday morning, Benzinga reports. Several other equities research analysts have also weighed in on the... More »

Cinemark (NYSE:CNK) Receives Buy Rating from Benchmark

Posted by Wayne Rhoads on Apr 1st, 2023

Benchmark reaffirmed their buy rating on shares of Cinemark (NYSE:CNK – Get Rating) in a research report released on Tuesday morning, Benzinga reports. They currently have a $17.00 target price on the stock. A number of other... More »

TELA Bio’s (TELA) “Buy” Rating Reiterated at Canaccord Genuity Group

Posted by Wayne Rhoads on Apr 1st, 2023

Canaccord Genuity Group reiterated their buy rating on shares of TELA Bio (NASDAQ:TELA – Get Rating) in a research note issued to investors on Tuesday, Benzinga reports. The firm currently has a $15.00 price target on the stock. Separately,... More »

Erste Group Bank Reaffirms Hold Rating for Walmart (NYSE:WMT)

Posted by Wayne Rhoads on Apr 1st, 2023

Erste Group Bank reissued their hold rating on shares of Walmart (NYSE:WMT – Get Rating) in a research note released on Tuesday, Benzinga reports. Several other equities research analysts have also issued reports on the stock.... More »

IceCure Medical (NASDAQ:ICCM) Receives Buy Rating from HC Wainwright

Posted by Wayne Rhoads on Apr 1st, 2023

HC Wainwright reissued their buy rating on shares of IceCure Medical (NASDAQ:ICCM – Get Rating) in a report published on Tuesday, Benzinga reports. They currently have a $3.00 price objective on the stock. IceCure Medical Stock... More »

Enthusiast Gaming (NASDAQ:EGLX) Given New $3.50 Price Target at Canaccord Genuity Group

Posted by Wayne Rhoads on Apr 1st, 2023

Enthusiast Gaming (NASDAQ:EGLX – Get Rating) had its price objective cut by Canaccord Genuity Group from $4.50 to $3.50 in a research note issued to investors on Tuesday morning, Benzinga reports. They currently have a buy rating... More »

The Latest Headlines at Zolmax